Literature DB >> 8762037

Chemical versus isotopic equilibrium and the metabolic fate of glycolytic end products in the heart.

L A Damico1, L T White, X Yu, E D Lewandowski.   

Abstract

Recent studies of isotope exchange across lactate dehydrogenase (LDH) and alanine aminotransferase (AAT) in hearts call into question whether both reactions are in equilibrium. To compare the oxidative and non-oxidative fates of glycolytic end products, isolated rabbit hearts were perfused with 5 mM [2-13C] glucose and 2.5 mM [3-13C] pyruvate: with (n = 6) and without (n = 7) stimulation of pyruvate oxidation using dichloroacetate (DCA), and during normal perfusion or hypoxia (n = 7/n = 6, +/- DCA). 13C NMR spectroscopy of intact hearts confirmed a steady-state enrichment level in both alanine and lactate. 1H- and 13C-NMR spectroscopy of tissue extracts identified the fractions of lactate, alanine and glutamate pools formed from each exogenous substrate. Glycolysis from glucose accounted for 22 +/- 7% of lactate formed and 10 +/- 2% of alanine formed in control hearts, and 16 +/- 2% lactate and 15 +/- 2% alanine in hypoxic hearts (mean +/- S.E.M.). In contrast, exogenous pyruvate formed 36 +/- 5% of the lactate pool, and 86 +/- 3% of the alanine pool in controls and 47 +/- 3% of lactate and of 67 +/- 3% alanine during hypoxia. [2(-13)C] glucose did not contribute to oxidative energy production via the TCA cycle as determined from low 13C enrichment of glutamate C5 from glucose (< 2%), while [3-13C] pyruvate accounted for 84 +/- 7% of labeled glutamate C4. Thus, exogenous pyruvate out-competed the metabolism of glucose, indicating low glycolytic activity. At 40 min, 96 +/- 2% of the total alanine was labeled from either glucose or pyruvate, confirming equilibrium at AAT. However, only 55 +/- 10% of total lactate was labeled, suggesting that the LDH reaction is not in rapid equilibrium within the myocardium.

Entities:  

Mesh:

Year:  1996        PMID: 8762037     DOI: 10.1006/jmcc.1996.0092

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

Review 1.  Cardiac carbon 13 magnetic resonance spectroscopy: on the horizon or over the rainbow?

Authors:  E Douglas Lewandowski
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

2.  Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia.

Authors:  Raymond K Kudej; Mathew Fasano; Xin Zhao; Gary D Lopaschuk; Susan K Fischer; Dorothy E Vatner; Stephen F Vatner; E Douglas Lewandowski
Journal:  Cardiovasc Res       Date:  2011-08-11       Impact factor: 10.787

3.  Recruitment of NADH shuttling in pressure-overloaded and hypertrophic rat hearts.

Authors:  E Douglas Lewandowski; J Michael O'donnell; Thomas D Scholz; Natalia Sorokina; Peter M Buttrick
Journal:  Am J Physiol Cell Physiol       Date:  2007-01-17       Impact factor: 4.249

Review 4.  Advantages and limitations of experimental techniques used to measure cardiac energy metabolism.

Authors:  G D Lopaschuk
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

5.  Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia.

Authors:  Kayla M Pound; Grace M Arteaga; Mathew Fasano; Tanganyika Wilder; Susan K Fischer; Chad M Warren; Adam R Wende; Mariam Farjah; E Dale Abel; R John Solaro; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2011-05-26       Impact factor: 5.000

6.  The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover.

Authors:  J Michael O'Donnell; Aaron D Fields; Natalia Sorokina; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2007-11-24       Impact factor: 5.000

7.  Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.

Authors:  Kayla M Pound; Natalia Sorokina; Kalpana Ballal; Deborah A Berkich; Mathew Fasano; Kathryn F Lanoue; Heinrich Taegtmeyer; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

8.  Pyruvate modulates cardiac sarcoplasmic reticulum Ca2+ release in rats via mitochondria-dependent and -independent mechanisms.

Authors:  Aleksey V Zima; Jens Kockskämper; Rafael Mejia-Alvarez; Lothar A Blatter
Journal:  J Physiol       Date:  2003-06-24       Impact factor: 5.182

9.  Ethanol inhalation on 1-[14C]-pyruvate kinetics in mice using a six-compartment closed model.

Authors:  G Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.569

10.  Modeling non-linear kinetics of hyperpolarized [1-(13)C] pyruvate in the crystalloid-perfused rat heart.

Authors:  E Mariotti; M R Orton; O Eerbeek; J F Ashruf; C J Zuurbier; R Southworth; T R Eykyn
Journal:  NMR Biomed       Date:  2016-01-18       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.